January 5, 2024 07:02 AM ESTUpdated January 6, 03:34 AM

Evotec CEO Werner Lanthaler resigns; After Novo deal, ex-Forma chief ushers in new era at Pacira

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Werner Lanthaler announced his resignation as CEO of serial Big Pharma partner Evotec on Wednesday, and his former COO Mario Polywka will fill in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Evotec CEO Werner Lanthaler resigns; After Novo deal, ex-Forma chief ushers in new era at Pacira

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Evotec CEO Wern­er Lan­thaler re­signs; Af­ter No­vo deal, ex-For­ma chief ush­ers in new era at Paci­ra

Copy Chief

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Evotec CEO Werner Lanthaler resigns; After Novo deal, ex-Forma chief ushers in new era at Pacira